Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study
IAS may be an effective adjunctive therapy in patients refractory to GC and conventional treatments, leading to rapid CK level reductions, decreased GC usage and improvements in PCSA and muscle function.
Authors
- Helga Radner (ORCID: https://orcid.org/0000-0002-5908-1525)
- Roman Reindl‐Schwaighofer (ORCID: https://orcid.org/0000-0002-4419-6282)
- Kastriot Kastrati (ORCID: https://orcid.org/0000-0002-1393-3390)
- H. Rajab
- Michael Bonelli (ORCID: https://orcid.org/0000-0002-6122-7482)
- Sahra Pajenda
- Thomas Karonitsch (ORCID: https://orcid.org/0000-0001-8310-6211)
- Kurt Derfler (ORCID: https://orcid.org/0000-0003-2062-7620)
- Peter Maximilian Heil (ORCID: https://orcid.org/0000-0003-4326-2871)
- Farsad Alexander Eskandary (ORCID: https://orcid.org/0000-0002-8971-6149)
- Daniel Mrak (ORCID: https://orcid.org/0000-0001-5321-6751)
- Hans P. Kiener (ORCID: https://orcid.org/0000-0002-5391-1954)
- Daniel Aletaha
- Josef S Smolen
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1093/rheumatology/keaf289
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 1.35